Skip to Content

Board of Directors

Scientific Advisory Board

SGK1 Inhibition

Clinical Studies

Long QT Syndrome (cLQTS)

Acquired Long QT

Atrial Fibrillation

Shared Stories & Blog

Canada: English

Canada: Français

United States

Board of Directors

Scientific Advisory Board

SGK1 Inhibition

Clinical Studies

Long QT Syndrome (cLQTS)

Acquired Long QT

Atrial Fibrillation

Shared Stories & Blog

Canada: English

Canada: Français

United States

Folder: About Us

Board of Directors

Scientific Advisory Board

Folder: Pipeline R&D

SGK1 Inhibition

Clinical Studies

Folder: Focus Areas

Long QT Syndrome (cLQTS)

Acquired Long QT

Atrial Fibrillation

Folder: News & Info

Shared Stories & Blog

Canada: English

Canada: Français

United States

Contact us

Thryv Therapeutics Inc.

Location: 999 Blvd. De Maisonneuve West, Suite 1250, Montreal, Quebec H3A 3L4 Canada

Email: admin@thryvtrx.com

Phone: +1 (514) 973-0915

Thryv Therapeutics Inc.

999 Blvd. De Maisonneuve West, Suite 1250, Montreal, Quebec | admin@thryvtrx.com | +1 (514) 973-0915

© Thryv Therapeutics Inc. All rights reserved. Privacy Policy. Terms of Use.

Created by Snowed Under Solutions